DK0873136T3 - Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme - Google Patents

Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme

Info

Publication number
DK0873136T3
DK0873136T3 DK96939501T DK96939501T DK0873136T3 DK 0873136 T3 DK0873136 T3 DK 0873136T3 DK 96939501 T DK96939501 T DK 96939501T DK 96939501 T DK96939501 T DK 96939501T DK 0873136 T3 DK0873136 T3 DK 0873136T3
Authority
DK
Denmark
Prior art keywords
pct
factor
specific immune
date
methods
Prior art date
Application number
DK96939501T
Other languages
English (en)
Inventor
Geoffrey M Thiele
Thomas L Mcdonald
Dean J Tuma
Lynell W Klassen
Michael F Sorrell
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nebraska filed Critical Univ Nebraska
Application granted granted Critical
Publication of DK0873136T3 publication Critical patent/DK0873136T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012Haptens, e.g. di- or trinitrophenyl (DNP, TNP)

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
DK96939501T 1995-10-27 1996-10-25 Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme DK0873136T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US595995P 1995-10-27 1995-10-27
PCT/US1996/017240 WO1997015324A1 (en) 1995-10-27 1996-10-25 High fluorescence specific immune enhancing factor and methods of use for same

Publications (1)

Publication Number Publication Date
DK0873136T3 true DK0873136T3 (da) 2005-01-24

Family

ID=21718568

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96939501T DK0873136T3 (da) 1995-10-27 1996-10-25 Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme

Country Status (9)

Country Link
US (1) US6120777A (da)
EP (1) EP0873136B1 (da)
JP (1) JP2000505056A (da)
AT (1) ATE279207T1 (da)
AU (1) AU726344B2 (da)
CA (1) CA2235599A1 (da)
DE (1) DE69633635T2 (da)
DK (1) DK0873136T3 (da)
WO (1) WO1997015324A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100680014B1 (ko) * 1997-10-03 2007-02-09 갈레니카 파마슈티칼스 인크. 이민 형성 폴리사카라이드, 이의 제조 방법 및 이것의 아쥬반트 및 면역자극제로서의 용도
GB0326439D0 (en) * 2003-11-13 2003-12-17 Imp College Innovations Ltd Methods

Also Published As

Publication number Publication date
EP0873136A4 (en) 2001-11-07
AU7665496A (en) 1997-05-15
WO1997015324A1 (en) 1997-05-01
ATE279207T1 (de) 2004-10-15
EP0873136B1 (en) 2004-10-13
US6120777A (en) 2000-09-19
DE69633635D1 (de) 2004-11-18
EP0873136A2 (en) 1998-10-28
DE69633635T2 (de) 2006-03-09
AU726344B2 (en) 2000-11-02
CA2235599A1 (en) 1997-05-01
JP2000505056A (ja) 2000-04-25

Similar Documents

Publication Publication Date Title
IL134392A0 (en) Vaccine against hpv
BR9814487A (pt) "vacina"
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
TR199801722T2 (xx) Peptit imm�nojenler.
ATE231917T1 (de) Immunresponse gegen hpv antigene erregt von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einen expressionsvektor fähig zur expression dieser proteine
ATE454163T1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
DK0817846T3 (da) Intracellulært domæne af HER-2/neu proteinet til forebyggelse eller behandling af maligniteter
WO2003045128A3 (en) SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
ATE125157T1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
NO20013701L (no) HER-2/neu-fusjonsproteiner
NO924780L (no) Ekspresjon av spesifikke immunogener ved bruk av virusantigener
DE69431404D1 (de) Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
DE69429723D1 (de) Stressproteine und ihre verwendung
JPS56131523A (en) Vaccine composite containing idiosyncratic antigen and vaccine containing idiosyncratic antigen
BR9906927A (pt) Proteìnas de neisseria meningitidis
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
DK0555276T3 (da) Immunogene komplekser, især iscomer
WO2000056901A3 (en) Linear and circular expression elements
AU2316892A (en) Multiple emulsions and methods of preparation
DE69727595D1 (de) Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung
NO20024571D0 (no) Immunoterapeutiske fremgangsmåter og blandinger
AU691995B2 (en) Interference-suppressing reagent specific to certain classes of antibodies
EP0602046A4 (en) DETECTING THE MAMMAL VIRUS WEAK VIRUS.
ES2196150T3 (es) Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.
DE69229269D1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik